Ginkgo Bioworks Holdings (DNA) Revenue (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) has 7 years of Revenue data on file, last reported at $19.5 million in Q1 2026.

• Quarterly Revenue fell 49.06% year-over-year to $19.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $141.3 million (down 37.84% YoY) and the FY2025 annual result came in at $170.2 million, down 25.06% from the prior year.
• Revenue fell to $19.5 million in Q1 2026, from $33.4 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $243.1 million in Q4 2023 to a low of $19.5 million in Q1 2026.
• A 5-year average of $79.1 million and a median of $56.2 million in 2024 frame the typical range for Revenue.
• Annual changes were most pronounced in 2022 — Revenue surged 281.9% — and 2024, when it sank 81.96%.
• Tracing DNA's Revenue over 5 years: stood at $98.3 million in 2022, then surged by 147.33% to $243.1 million in 2023, then slumped by 81.96% to $43.8 million in 2024, then slipped by 23.84% to $33.4 million in 2025, then sank by 41.69% to $19.5 million in 2026.
• The last three Revenue figures came in at $19.5 million (Q1 2026), $33.4 million (Q4 2025), and $38.8 million (Q3 2025), per Business Quant data.